Call Options Transactions Made in Q2 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q2 2024. The information is specifically focused on institutions that hold call options of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Stem Point Capital LP
New York, NY |
BUY
|
CALL |
5MNew |
$36.2M - $62.7M
|
5M
$46.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
74.3KNew |
$538K - $931K
|
74.3K
$688K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
71.7KNew |
$519K - $898K
|
71.7K
$664K
|
|
|
Aug 13, 2024
Q2 2024
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
40.5KNew |
$293K - $507K
|
40.5K
$375K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-4.7K- 5.53% |
$34K - $58.9K
|
80.3K
$744K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-250K- 60.67% |
$1.81M - $3.14M
|
162K
$1.5M
|
|
|
Aug 13, 2024
Q2 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
CALL |
-4.5M- 90.0% |
$32.6M - $56.4M
|
500K
$4.63M
|